Home › Breast Cancer › California › Newport Beach
Breast Cancer clinical trials in Newport Beach, CA
16 studies for Breast Cancer are looking for participants at sites in and around Newport Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecruitingPhase 1
- Research Site, Newport Beach
IKS014 in Advanced Solid Tumors That Express HER2
RecruitingPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RecruitingPhase 3
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Hoag Memorial Hospital Presbyterian ( Site 0010), Newport Beach
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RecruitingPhase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecruitingPhase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecruitingPhase 1
- Hoag Family Cancer Institute, Newport Beach
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RecruitingPhase 2/3
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
RecruitingPhase 1
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecruitingPhase 2
- HOAG Memorial Hospital Presbyterian, Newport Beach
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
RecruitingObservational study
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecruitingPhase 3
- City of Hope Newport Beach, Newport Beach
Perioperative Mindfulness Proposal
Recruiting
- Hoag Memorial Hospital Presbyterian, Newport Beach
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Newport Beach
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer10 studies
- COPD9 studies
- Ovarian Cancer9 studies
- Endometrial Cancer7 studies
- Lung Cancer7 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Triple-Negative Breast Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.